Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Revenue

In the year 2025, Sangamo Therapeutics had annual revenue of $39.55M, down -31.57%. Sangamo Therapeutics had revenue of $14.23M in the quarter ending December 31, 2025, with 88.43% growth.

• Revenue: 39.55M
• Revenue Growth: -31.57%
• P/S Ratio: 2.09
• Revenue / Employee: 243.36K
• Employees: 142
• Market Cap: 72.21M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	39.55M	-18.25M	-31.57%
Dec 31, 2024	57.80M	-118.43M	-67.20%
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%
Dec 31, 2019	102.43M	17.98M	21.29%
Dec 31, 2018	84.45M	47.89M	130.95%
Dec 31, 2017	36.57M	17.18M	88.60%
Dec 31, 2016	19.39M	-20.15M	-50.96%
Dec 31, 2015	39.54M	-6.33M	-13.80%
Dec 31, 2014	45.87M	21.74M	90.07%
Dec 31, 2013	24.13M	2.48M	11.44%
Dec 31, 2012	21.66M	11.34M	109.86%
Dec 31, 2011	10.32M	-10.49M	-50.40%
Dec 31, 2010	20.81M	-1.38M	-6.23%
Dec 31, 2009	22.19M	6.00M	37.08%
Dec 31, 2008	16.19M	7.09M	77.91%
Dec 31, 2007	9.10M	1.21M	15.38%
Dec 31, 2006	7.89M	5.40M	217.43%
Dec 31, 2005	2.48M	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error